Literature DB >> 7805651

Biochemical and radiologic diagnosis of Cushing's syndrome.

J W Findling1, J L Doppman.   

Abstract

In summary, the technological advances in the past decade have greatly improved the biochemical and radiological diagnosis of Cushing's syndrome. Figure 13 illustrates an algorithm for the differential diagnosis of Cushing's syndrome that focuses on the importance of ACTH-IRMA and provides two potential diagnostic approaches for the evaluation of ACTH-dependent hypercortisolism. The first approach directly proceeds to IPSS as the most rapid and possibly most cost effective method to establish an accurate diagnosis. A more traditional approach employs high dose dexamethasone suppression testing followed by MR studies of the pituitary. If the biochemical or radiological studies are the least bit equivocal, IPSS should be performed before definitive therapy is recommended.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7805651

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  15 in total

Review 1.  Cushing's syndrome.

Authors:  V Bhatia
Journal:  Indian J Pediatr       Date:  1997 Mar-Apr       Impact factor: 1.967

2.  New targets for the clinical assessment of salivan cortisol secretion.

Authors:  R Rosmond; P Björntorp
Journal:  J Endocrinol Invest       Date:  2001-09       Impact factor: 4.256

3.  Role of bilateral inferior petrosal sinus sampling (BIPSS) in the diagnosis of Cushing's disease in a patient with double superior vena cava.

Authors:  Sonam Tashi; Keng Sin Ng
Journal:  J Radiol Case Rep       Date:  2015-08-31

4.  Selective inferior petrosal sinus sampling without venous outflow diversion in the detection of a pituitary adenoma in Cushing's syndrome.

Authors:  Lukas Andereggen; Gerhard Schroth; Jan Gralla; Rolf Seiler; Luigi Mariani; Jürgen Beck; Hans-Rudolf Widmer; Robert H Andres; Emanuel Christ; Christoph Ozdoba
Journal:  Neuroradiology       Date:  2011-08-02       Impact factor: 2.804

5.  The dexamethasone-suppressed corticotropin-releasing hormone stimulation test differentiates mild Cushing's disease from normal physiology.

Authors:  J A Yanovski; G B Cutler; G P Chrousos; L K Nieman
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

6.  Coexistence of unilateral adrenal macronodule and Cushing's disease. Report of two cases.

Authors:  G Borretta; M Terzolo; F Cesario; I Meineri; A Pia; A Angeli
Journal:  J Endocrinol Invest       Date:  1996-02       Impact factor: 4.256

7.  Cushing's paraneoplastic syndrome as first manifestation of an adenocarcinoma of unknown origin.

Authors:  María José Molina Garrido; Carmen Guillén Ponce; Sonia Maciá Escalante; Vanesa Pons Sanz; Alfredo Carrato Mena
Journal:  Clin Transl Oncol       Date:  2006-08       Impact factor: 3.405

8.  A Minimally Invasive Approach to the Management of Bronchial Carcinoid Tumors Associated with Ectopic Cushing's Syndrome.

Authors:  Niall D. Ferguson; Eric C. Poulin; Victor L. Fornasier; Harley S. Smyth; Shereen Ezzat
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

9.  Plurihormonal Bronchial Carcinoid Associated with Ectopic Cushing's Syndrome.

Authors:  Donna Battaglia; Kalman Kovacs; Eva Horvath; Eric Poulin; Harley S. Smyth
Journal:  Endocr Pathol       Date:  1999       Impact factor: 3.943

10.  Clinicopathological variations in cushing's syndrome.

Authors:  G L Booth; H S Smyth; K Kovacs; E Horvath; S L Asa; S Ezzat
Journal:  Endocr Pathol       Date:  1999-06       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.